Current Treatments for COPD
Links shared publicly online about this topic.
- 552total visits
Current Treatments for COPD
View full resource at suite101.com
Tags: COPD, Drug, Exercise and Fitness
Most Recently Shared on January 26, 2011 at 8:50 pm By:
AstraZeneca's Susan Galbraith on the current focus areas in cancer treatment - YouTube
youtube.com — “AstraZeneca's Susan Galbraith, Head of Oncology Innovative Medicines Unit, talks about the current focus areas in cancer treatment and the importance of coll...” View full resource at youtube.com
Most Recently Shared on April 3, 2012 at 10:53 am By:
Head of Oncology Susan Galbraith iMed Unit at #AACR describing how AZ is tackling #cancer http://t.co/hJAqo4g7
A.M. Vitals: Some States Move Forward Voluntarily on Health-Insurance Exchanges - Health Blog - WSJ
blogs.wsj.com — “Also: Melanoma rates have increased "dramatically," Mayo Clinic researchers say; Express Scripts closes its acquisition of Medco; and a Novartis COPD treatment met its main goals in three late-stage trials.” View full resource at blogs.wsj.com
Most Recently Shared on April 2, 2012 at 10:34 pm By:
A.M. Vitals: Some States Move Forward Voluntarily on Health-Insurance Exchanges http://t.co/lkTfOB8z
Elsevier
jhandsurg.org — “Elsevier” View full resource at jhandsurg.org
Most Recently Shared on March 31, 2012 at 1:36 am By:
Re: “Current Trends in Nonoperative and Operative Treatment of Trapeziometacarpal Osteoarthritis: A Survey of US... http://t.co/bFN4aukN
Elsevier
jhandsurg.org — “Elsevier” View full resource at jhandsurg.org
Most Recently Shared on March 31, 2012 at 1:36 am By:
Re: “Current Trends in Nonoperative and Operative Treatment of Trapeziometacarpal Osteoarthritis: A Survey of US... http://t.co/bL2LicId
Clovis Oncology Announces Enrollment of First Patient in First Human Study of Oral EGFR Mutant-Selective Inhibitor CO-1686 - Yahoo! News
news.yahoo.com — “From Yahoo! News: Clovis Oncology, Inc. (Nasdaq: CLVS) announced today that the first clinical study of CO-1686 has commenced with the dosing of the first patient at a U.S. study site. CO-1686 is a novel, oral, targeted covalent inhibitor of epidermal growth factor receptor (EGFR) mutations currently being studied for the treatment of non-small cell lung cancer (NSCLC).” View full resource at news.yahoo.com
Most Recently Shared on March 28, 2012 at 11:04 am By:
Clovis Oncology Announces Enrollment of First Patient in First Human Study of Oral EGFR Mutant-Selective Inhibit... http://t.co/48JzhFAO
Clinical Pharmacology & Therapeutics - Current Understanding of Rheumatoid Arthritis Therapy
nature.com — “Clinical Pharmacology & Therapeutics, the most cited journal publishing primary investigation in pharmacology and pharmacy, is the authoritative, cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy and evaluation of therapeutics.” View full resource at nature.com
Most Recently Shared on March 28, 2012 at 4:08 am By:
Dr OP Garg Internist, Rheumatologist, Physician, and Doctor
Good morning: For those who wants to know more about the details of treatment, especially medical professionals... http://t.co/upcJ2KMK
An Alternative Cancer Treatment Plan - Video - iHealthTube.com
ihealthtube.com — “Dr. Tony Jimenez discusses his background and how he got into alternative cancer treatments. He also discusses how he started his current clinic and what some of the principals that are stressed at the clinic.” View full resource at ihealthtube.com
Most Recently Shared on March 27, 2012 at 7:30 pm By:
An Alternative Cancer Treatment Plan - Video - http://t.co/5f8i4HLz http://t.co/DjvZFoSI
Decade-Long Study Raises New Questions About Antibiotic Use for Cystic Fibrosis
newswise.com — “When it comes to treating cystic fibrosis, the current standard of aggressive antibiotic treatments may not always be the best answer, a decade-long study led by researchers at the University of Michigan has found.” View full resource at newswise.com
Most Recently Shared on March 26, 2012 at 7:43 pm By:
newswise Health News and Health Communicator
Decade-Long Study Raises New Questions About Antibiotic Use for Cystic Fibrosis http://t.co/0rUVWihJ
Decade-long study raises new questions about antibiotic use for cystic fibrosis
medicalxpress.com — “When it comes to treating cystic fibrosis, the current standard of aggressive antibiotic treatments may not always be the best answer, a decade-long study led by researchers at the University of Michigan has found.” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 6:57 pm By:
PhysOrg Health News Health News
Decade-long study raises new questions about antibiotic use for cystic fibrosis http://t.co/BdPdXmch
Third bill filed in Mo. Gen. Assembly to raise cigarette tax | St. Louis Public Radio
news.stlpublicradio.org — “Yet another bill has been filed in the General Assembly that would raise Missouri’s cigarette tax, currently the lowest in the nation.” View full resource at news.stlpublicradio.org
Most Recently Shared on March 26, 2012 at 4:05 pm By:
COPD Foundation Health Organization
RT @clebeau82: Third bill filed in Mo. Gen. Assembly to raise #cigarette tax http://t.co/vIxojP8T via @stlpublicradio #stl #smokefree #COPD
Where Will Kinase Inhibitors Fit into the RA Treatment Mix? :: Article - The Rheumatologist
the-rheumatologist.org — “CHICAGO - Presenters at ldquoLooking Ahead to Kinase Inhibition in Rheumatoid Arthritisrdquo delved into some of the big questions that rheumatology faces with kinase inhibitor use. The presentation, a session here at the 2011 ACRARHP Annual Scientific Meeting held in Chicago in November, gave an overview of the kinase inhibitors currently under...” View full resource at the-rheumatologist.org
Most Recently Shared on March 22, 2012 at 9:45 pm By:
AmerCollRheumatology Health Organization and Rheumatology
Where Will Kinase Inhibitors Fit into the RA Treatment Mix? http://t.co/vQzLeekh #rheumatology
Leukemia: Understanding its types and treatments - ONA
oncologynurseadvisor.com — “This review describes the four major groups of leukemia, plus diagnostic tests and current and emerging treatment regimens for each group.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 22, 2012 at 12:48 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Leukemia: Understanding its types and treatments http://t.co/20hvrTEL #Leukemia
Tenecteplase drug bests standard treatment for certain strokes
medicalxpress.com — “(HealthDay) -- A medication called tenecteplase may be more effective at treating strokes caused by clots in large blood vessels in the brain than the current standard therapy, Australian researchers report.” View full resource at medicalxpress.com
Most Recently Shared on March 22, 2012 at 12:07 pm By:
PhysOrg Health News Health News
New drug bests standard treatment for certain strokes http://t.co/ZvUQJal8
Advances in Neuroimmune Biology explores maternal-fetal interactions
news-medical.net — “Fertility problems, recurrent miscarriages, and pregnancy complications can occur when maternal immunological tolerance of the fetus is impaired. G-rard Chaouat and colleagues from Inserm et Assistance Publique et Universit- Paris Sud Orsay, Hopital Antoine B-cl-re, Clamart Cedex, France, trace the evolution of the science of reproductive immunology to show how the current understanding of maternal-fetal tolerance/dialogue has developed, and its implications for the treatment of infertility diso” View full resource at news-medical.net
Most Recently Shared on March 22, 2012 at 8:13 am By:
Pregnancy News: Advances in Neuroimmune Biology explores maternal-fetal interactions: Fertility problems, recurr... http://t.co/JBnNn3AJ
Low-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjects - HODGE - Respirology - Wiley Online Library
onlinelibrary.wiley.com — “Low-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjects - HODGE - Respirology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 21, 2012 at 11:49 am By:
Juan C. Ivancevich, MD Physician, Doctor, Internist, and Allergist
Long term use of low dose azithromycin as an attractive adjunct treatment option for COPD. http://t.co/7n2qaGUU
Advertisement
